326 related articles for article (PubMed ID: 31117966)
21. Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression.
Zhang JY; Liu JH; Liu FD; Xia YH; Wang J; Liu X; Zhang ZQ; Zhu N; Yan-Yan ; Ying Y; Huang XT
Mycoses; 2014 Oct; 57(10):584-91. PubMed ID: 24962255
[TBL] [Abstract][Full Text] [Related]
22. Molecular identification and antifungal susceptibility of 186 Candida isolates from vulvovaginal candidiasis in southern China.
Shi XY; Yang YP; Zhang Y; Li W; Wang JD; Huang WM; Fan YM
J Med Microbiol; 2015 Apr; 64(Pt 4):390-393. PubMed ID: 25596116
[TBL] [Abstract][Full Text] [Related]
23. Biased Genotype Distributions of Candida albicans Strains Associated with 649 Clinical Vulvovaginal Candidiasis in China.
Pang Q; Liu W; Cui F; Kan S; Li X
Mycopathologia; 2022 Dec; 187(5-6):427-437. PubMed ID: 36209322
[TBL] [Abstract][Full Text] [Related]
24. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Gao M; Wang H; Zhu L
Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
[TBL] [Abstract][Full Text] [Related]
25. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
Hacioglu M; Guzel CB; Savage PB; Tan ASB
Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
[TBL] [Abstract][Full Text] [Related]
26. Molecular epidemiology of invasive Candida albicans at a tertiary hospital in northern Taiwan from 2003 to 2011.
Wang SH; Shen M; Lin HC; Sun PL; Lo HJ; Lu JJ
Med Mycol; 2015 Nov; 53(8):828-36. PubMed ID: 26333357
[TBL] [Abstract][Full Text] [Related]
27. Genotyping and Drug Resistance Profile of Clinical Isolates of Candida albicans from Vulvovaginal Candidiasis in the Eastern China.
Hong N; Lei Y; Chen H; Chen X; Tsui KM; Hu D; Liao W; Yan L; Zhang H; Zhao R; Wu G; Yu N; Deng S
Mycopathologia; 2022 Jun; 187(2-3):217-224. PubMed ID: 35072854
[TBL] [Abstract][Full Text] [Related]
28. Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait.
Asadzadeh M; Ahmad S; Al-Sweih N; Khan Z
PLoS One; 2017; 12(4):e0175269. PubMed ID: 28380072
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of CDR1 and MDR1 efflux pump genes and fluconazole resistance are involved in recurrence in Candida albicans-induced vulvovaginal candidiasis.
Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
Diagn Microbiol Infect Dis; 2024 May; 109(1):116242. PubMed ID: 38452558
[TBL] [Abstract][Full Text] [Related]
30. Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil.
Boatto HF; Cavalcanti SD; Del Negro GM; Girão MJ; Francisco EC; Ishida K; Gompertz OF
Mem Inst Oswaldo Cruz; 2016 Jun; 111(6):407-10. PubMed ID: 27304096
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil.
Brandão LDS; Boniek D; Resende Stoianoff MA; da Mata FMR; de Azevedo PRM; Fernandes JV; Andrade VS
Lett Appl Microbiol; 2018 Sep; 67(3):285-291. PubMed ID: 29908032
[TBL] [Abstract][Full Text] [Related]
32. Candida africana vulvovaginitis: Prevalence and geographical distribution.
Fakhim H; Vaezi A; Javidnia J; Nasri E; Mahdi D; Diba K; Badali H
J Mycol Med; 2020 Sep; 30(3):100966. PubMed ID: 32317216
[TBL] [Abstract][Full Text] [Related]
33. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
[TBL] [Abstract][Full Text] [Related]
34. The changes of antifungal susceptibilities caused by the phenotypic switching of Candida species in 229 patients with vulvovaginal candidiasis.
Tang Y; Yu F; Huang L; Hu Z
J Clin Lab Anal; 2019 Jan; 33(1):e22644. PubMed ID: 30101450
[TBL] [Abstract][Full Text] [Related]
35. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.
Liu XP; Fan SR; Bai FY; Li J; Liao QP
Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300
[TBL] [Abstract][Full Text] [Related]
36. Antifungal susceptibility and molecular typing of 115 Candida albicans isolates obtained from vulvovaginal candidiasis patients in 3 Shanghai maternity hospitals.
Ying C; Zhang H; Tang Z; Chen H; Gao J; Yue C
Med Mycol; 2016 May; 54(4):394-9. PubMed ID: 26468549
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Candida albicans, Candida dubliniensis and Candida africana in pregnant women suffering from vulvovaginal candidiasis in Argentina.
Mucci MJ; Cuestas ML; Landanburu MF; Mujica MT
Rev Iberoam Micol; 2017; 34(2):72-76. PubMed ID: 28385421
[TBL] [Abstract][Full Text] [Related]
38. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
39. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
Adjapong G; Hale M; Garrill A
Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
[TBL] [Abstract][Full Text] [Related]
40. Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern.
Khaksar Baniasadi A; Ayatollahi Mosavi SA; Sharifi I; Bamorovat M; Salari S; Ahmadi A; Amanizadeh A; Agha Kuchak Afshari S
J Obstet Gynaecol Res; 2022 Dec; 48(12):3292-3303. PubMed ID: 36184563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
